Nationwide COVID-OUT treatment trial with ivermectin is underway
Phoenix Herald
23 Jul 2021, 10 GMT+10
An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nation s first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and long COVID.
Led by the University of Minnesota Medical School, the multi-site clinical trial received new support $1 million from the Rainwater Charitable Foundation and $500,000 from Fast Grants to expand the study, which is also the first randomized clinical trial for COVID-19 in the world to include pregnant women.
Study highlights socioeconomic, racial differences in the financing of medical education
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Chance That COVID-19 Vaccines Are Gene Therapy? Zero
webmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webmd.com Daily Mail and Mail on Sunday newspapers.
Chance That COVID-19 Vaccines Are Gene Therapy? Zero
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.